advanced search

Search within

Updates under

CSU 120/2011: INSECTICIDE RESISTANCE ACTION COMMIT ...

Dear  Robert, I was wondering if could send a link to the IRAC (Insecticide Resistance Action Committee) website on one of your forthcoming newsletters to announce the second edition of the IRAC Vector Manual. Please find a link to the IRAC Pub ... read more

CSU 121/2011: CHANGES IN THE BURDEN OF MALARIA IN ...

    Sub-Saharan Africa defies generalization. Many islands and archipelagos have made striking progress against malaria. In central Africa, with the exception of Rwanda, progress is scanty or poorly documented. Everywhere, the need for be ... read more

CSU 134/2011: A RESEARCH AGENDA FOR MALARIA ERADIC ...

Summary Points Full text is at http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000398Vaccines for malaria eradication need to have an impact on transmission rather than focusing on mortality and morbidity reduction alone V ... read more

CSU 141/2011: MASS CAMPAIGN BEDNET DISTRIBUTION IN ...

The phrase 'mass campaign' raises hackles among some advocates of integrated health services. But if you are trying rapidly to increase bednet coverage in malarious airways, is there any faster way to do so than through mass campaigns? From the abst ... read more

CSU 153/2011: AGAINST EUPHORIA

Those who believe that Africa is within shooting distance of malaria elimination may wish to reconsider their position after reading this article. One should qualify this Ugandan article in several ways: 1)      Local insu ... read more

CSU 151/2011: MALARIA RESEARCH IN AFRICA, 1948-200 ...

The majority of malaria RCT conducted in Africa report on drug treatment and prevention in children; there is need for more research done in pregnant women. Sources of funding, informed consent and trial quality were often poorly reported. Overall, c ... read more

CSU 157/2011: CDC GRAND ROUNDS: THE OPPORTUNITY FO ...

Note, in particular, the graphics showing changes over time in bednet utilization in countries which have measured this twice.Can we do better than 60 percent bednet utilization rates? Best viewed at http://www.cdc.gov/mmwr/preview/mmw ... read more

CSU 154/2011: ECONOMIC VALUE OF DENGUE VACCINE IN ...

‘A 50% efficacious vaccine was highly cost-effective [< 1x per capita gross domestic product (GDP) ($4,289)] up to a total vaccination cost of $60 and cost-effective [< 3x per capita GDP ($12,868)] up to a total vaccination cost of $200. ... read more